Capricor Therapeutics CAPR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$33.94M-12.5% | -$30.17M-22.8% | -$24.57M+5.2% | -$25.91M-6.2% | -$24.39M-243% | ||
| $534.67K+6.4% | $502.59K+1.6% | $494.73K+1.7% | $486.28K+19.9% | $405.45K+7.9% | ||
| $5.92M+54.1% | $3.84M-3.9% | $4M+9.6% | $3.65M-33.5% | $5.48M+139% | ||
| -$29.25M-24.1% | -$23.57M-19.7% | -$19.69M+2.2% | -$20.12M-213% | -$6.43M+56.5% | ||
| $5.12M+208% | $1.66M+2,881% | $55.84K-80.6% | $287.74K-67.9% | $896.01K+83.3% | ||
| -$154.64M-459% | $43.09M+170% | $15.95M+9.6% | $14.55M-39.1% | $23.89M+119% | ||
| $1.47M-99.4% | $248.82M+3,579,978% | $6.95K-64.5% | $19.58K-61.1% | $50.35K-99.9% | ||
| -$182.43M-168% | $268.34M— | —— | —— | $17.51M+131% | ||
| -$34.38M-36.2% | -$25.23M-27.8% | -$19.74M+3.3% | -$20.41M-178% | -$7.33M+52.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Capricor Therapeutics's cash flow data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.